Literature DB >> 4397913

Cardioselective beta-receptor stimulant properties of oxyfedrine.

W Osswald, S Guimarães.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4397913     DOI： 10.1007/bf00997090

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmakol


× No keyword cloud information.
  17 in total

1.  Active relfex dilatation in the innervated perfused hind leg of the dog.

Authors:  L BECK
Journal:  Am J Physiol       Date:  1961-07

2.  [Differential susceptibility to noradrenaline and isoprenaline effects in the isolated guinea pig atrium].

Authors:  W Osswald; S Guimarães; E Rodrigues Pereira
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

3.  Study on some selective beta-adrenoreceptor blocking effects of 1-(4-nitrophenyl)-1-hydroxy-2-methyl isoproylaminoethane (alpha-methyl INPEA).

Authors:  P Somani
Journal:  Br J Pharmacol       Date:  1969-11       Impact factor: 8.739

4.  [Comparative studies on the question of differentiation of adrenergic beta-receptors].

Authors:  P Mentz; B Bayer; U Wartner; W Förster
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-09

5.  Adrenergic receptors in the veins of the dog.

Authors:  S Guimarães; W Osswald
Journal:  Eur J Pharmacol       Date:  1969-01       Impact factor: 4.432

6.  [Neurogenic vasodilatation caused by sympathomimetics].

Authors:  W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

7.  Cardiac effects of oxyfedrine in the cat.

Authors:  A R Thalinger; A M Lefer
Journal:  Eur J Pharmacol       Date:  1970       Impact factor: 4.432

8.  Effects of oxyfedrine on cardiac performance efficiency and coronary flow with respect to its mode of action.

Authors:  W R Kukovetz; G Pöch
Journal:  Brux Med       Date:  1970-09

9.  Pharmacological characterization of adrenergic receptors.

Authors:  N C Moran
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

10.  Salbutamol: a new, selective beta-adrenoceptive receptor stimulant.

Authors:  V A Cullum; J B Farmer; D Jack; G P Levy
Journal:  Br J Pharmacol       Date:  1969-01       Impact factor: 8.739
View more
  9 in total

1.  Excretion of norephedrine by man after oral administration of oxyfedrine.

Authors:  E Appel; G Planz; D Palm; H Grobecker; D Stratmann; M Donike
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

2.  Potentation of the cardiac response to aminophylline by oxyfedrine.

Authors:  K Sakai; G Pöch; W R Kukovetz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

3.  Noradrenaline depleting effect and metabolism of oxyfedrine in rats.

Authors:  E Appel; G Planz; B Schmid; D Palm; H Grobecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Effects of oxyfedrine and ouabain on the heart-lung preparation of the dog.

Authors:  K Sakai; S Sugano; C Isono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Inhibition of adrenergic cardiopathies by drugs. 3. Oxyfedrin.

Authors:  F W Eichbaum; W J Yasaka; E P dos Campos; S Zyngier
Journal:  Basic Res Cardiol       Date:  1973 Jul-Aug       Impact factor: 17.165

6.  The dual action of oxyfedrine on cardiac contractility.

Authors:  W Brandt; F Ebner; M Reiter; K Seibel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

7.  Cardioprotection by oxyfedrine in hereditary cardiomyopathic hamsters.

Authors:  K Lossnitzer; A Konrad; W Mohr; M Jakob; F Stroman
Journal:  Basic Res Cardiol       Date:  1979 Nov-Dec       Impact factor: 17.165

8.  The haemodynamic effects of prolonged oral administration of oxyfedrine, a partial agonist at beta-adrenoceptors: comparison with propranolol.

Authors:  J R Parratt
Journal:  Br J Pharmacol       Date:  1974-05       Impact factor: 8.739

9.  Effects of oxyfedrine on isolated portal vein and other smooth muscles.

Authors:  J E Mackenzie; J R Parratt
Journal:  Br J Pharmacol       Date:  1973-04       Impact factor: 8.739
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.